Avalo Therapeutics, Inc. (AVTX) has 20 known insider and institutional holders on record. The largest holder is Boyd Steven with 47,576,000 shares. Other notable holders include Ball Gary Edward and Jones Randal.
Over the last 12 months, insiders have made 40 transactions in AVTX stock — 22 buys (valued at $18.54M) and 5 sells (valued at $624.87K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
AVTX Insider Ownership
Top Holder
Boyd Steven
47,576,000 shares
Buys (12 mo)
22
$18.54M value
Sells (12 mo)
5
$624.87K value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Boyd Steven |
Director |
47,576,000 |
2022-03-14 |
|
| 2 |
Ball Gary Edward |
10 Percent Owner, Officer: President |
15,500,000 |
2005-11-02 |
|
| 3 |
Jones Randal |
10 Percent Owner |
3,767,442 |
2018-10-18 |
|
| 4 |
Moscato Robert Jr. |
10 Percent Owner |
3,767,442 |
2018-10-18 |
|
| 5 |
Armistice Capital, Llc |
10 Percent Owner |
1,668,862 |
2023-06-28 |
|
| 6 |
Crutcher Patrick J |
VP, Business Development |
1,634,771 |
2019-04-02 |
|
| 7 |
Caissa Capital Management Ltd. |
10 Percent Owner |
1,420,700 |
2023-06-20 |
|
| 8 |
Phillips Matthew V |
Chief Commercial Officer |
512,500 |
2019-10-21 |
|
| 9 |
Smolinski Stephen |
Chief Commercial Officer |
400,000 |
2022-01-06 |
|
| 10 |
Pedder Simon |
Executive Chairman of the Bd |
241,833 |
2020-04-13 |
|
| 11 |
Paterson Blake M |
CEO and President |
160,000 |
2015-10-20 |
|
| 12 |
Morris Mariam E |
Chief Financial Officer |
100,000 |
2018-01-24 |
|
| 13 |
Boyd Taylor |
Chief Business Officer |
95,000 |
2026-03-02 |
|
| 14 |
Riley Jennifer |
Chief Strategy Officer |
95,000 |
2026-03-02 |
|
| 15 |
Varki Paul |
Chief Legal Officer |
80,000 |
2026-03-02 |
|
| 16 |
Cola Michael F |
Chief Executive Officer |
78,116 |
2021-10-04 |
|
| 17 |
Neil Garry Arthur |
Chief Executive Officer |
64,867 |
2026-03-31 |
|
| 18 |
Calias Pericles |
Chief Scientific Officer |
49,216 |
2020-04-17 |
|
| 19 |
Marcus Ronald |
Chief Medical Officer |
40,000 |
2016-08-19 |
|
| 20 |
Barer Sol J |
Director |
40,000 |
2021-06-17 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-04-01 |
Doyle Mittie |
Chief Medical Officer |
Informative Sell |
679 |
$16.00 |
$10.86K |
| 2026-04-02 |
Sullivan Christopher Ryan |
Chief Financial Officer |
Informative Sell |
1,780 |
$17.57 |
$31.27K |
| 2026-04-01 |
Sullivan Christopher Ryan |
Chief Financial Officer |
Informative Sell |
7,479 |
$16.83 |
$125.84K |
| 2026-03-31 |
Jain Rita |
Director |
RSU Award |
1,339 |
$14.93 |
$19.99K |
| 2026-03-31 |
Lind Kevin Robert |
Director |
RSU Award |
1,370 |
$14.93 |
$20.45K |
| 2026-03-28 |
Truex Samantha |
Director |
Option Exercise (Sell) |
3,166 |
- |
- |
| 2026-03-28 |
Goldman Jonathan |
Director |
Option Exercise |
3,166 |
- |
- |
| 2026-03-28 |
Kantoff Aaron |
Director |
Option Exercise (Sell) |
3,166 |
- |
- |
| 2026-03-28 |
Sullivan Christopher Ryan |
Chief Financial Officer |
Option Exercise (Sell) |
24,200 |
- |
- |
| 2026-03-28 |
Chan Mitchell |
Director |
Option Exercise (Sell) |
3,166 |
- |
- |
| 2026-03-28 |
Neil Garry Arthur |
Chief Executive Officer |
Option Exercise (Sell) |
64,866 |
- |
- |
| 2026-03-28 |
Kaplan Gilla |
Director |
Option Exercise (Sell) |
3,166 |
- |
- |
| 2026-03-16 |
Doyle Mittie |
Chief Medical Officer |
Informative Sell |
25,492 |
$16.15 |
$411.61K |
| 2026-02-26 |
Boyd Taylor |
Chief Business Officer |
RSU Award |
95,000 |
$17.64 |
$1.68M |
| 2026-02-26 |
Riley Jennifer |
Chief Strategy Officer |
RSU Award |
95,000 |
$17.64 |
$1.68M |
| 2026-02-26 |
Doyle Mittie |
Chief Medical Officer |
RSU Award |
105,000 |
$17.64 |
$1.85M |
| 2026-02-26 |
Sullivan Christopher Ryan |
Chief Financial Officer |
RSU Award |
105,000 |
$17.64 |
$1.85M |
| 2026-02-26 |
Varki Paul |
Chief Legal Officer |
RSU Award |
80,000 |
$17.64 |
$1.41M |
| 2026-02-26 |
Neil Garry Arthur |
Chief Executive Officer |
RSU Award |
286,000 |
$17.64 |
$5.05M |
| 2025-12-31 |
Jain Rita |
Director |
RSU Award |
1,043 |
$18.16 |
$18.94K |
| 2025-12-31 |
Lind Kevin Robert |
Director |
RSU Award |
848 |
$18.16 |
$15.4K |
| 2025-12-10 |
Riley Jennifer |
Chief Strategy Officer |
Tax Withholding of RSU |
637 |
$4.10 |
$2.61K |
| 2025-12-10 |
Doyle Mittie |
Chief Medical Officer |
Tax Withholding of RSU |
1,013 |
$4.10 |
$4.15K |
| 2025-12-10 |
Sullivan Christopher Ryan |
Chief Financial Officer |
Tax Withholding of RSU |
155 |
$4.10 |
$635.50 |
| 2025-12-10 |
Varki Paul |
Chief Legal Officer |
Tax Withholding of RSU |
1,016 |
$4.10 |
$4.17K |
